Food and Drug Administration (FDA) Commissioner Marty Makary has directed the removal of bold warning labels on hormone replacement therapies

Food and Drug Administration (FDA) Commissioner Marty Makary has directed the removal of bold warning labels on hormone replacement therapies

The US health regulatory agency on Monday said it would direct manufacturers to remove a bold warning on many hormone therapies used to alleviate menopausal symptoms, saying the risks have been exaggerated.

Hormone Replacement Therapy can be taken to replace estrogen that the body stops producing during menopause -- the natural process that ends female reproductive years -- with the aim of alleviating symptoms that can be physically and mentally debilitating including hot flashes, brain fog, insomnia, night sweats, joint pain and bone loss.

Originally published on doc.afp.com, part of the BLOX Digital Content Exchange.